Skip to content

German G-POEM Trial

German G-POEM Trial - gGPT

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00033295
Enrollment
300
Registered
2024-01-18
Start date
2024-04-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K31.3 K31.8 G99.0

Interventions

Group 1: pre-interventional: upper GI-Endoscopy, objective gastric emptying study (C13-Breath-test, Gastric scintigraphy), if available Endo-Flip
EQ-5L-5D Trial begin: gastric peroral endoscopic myotomy post-interventional 3-6 month: GCSI-Score, objective gastric emptying study (C13-Breath-test, Gastric scintigraphy), if available Endo-Flip
EQ-5L-5D post-interventional 12 month: objective gastric emptying study (C13-Breath-test, Gastric scintigraphy), if available Endo-Flip
post-interventional 24 month: objective gastric emptying study (C13-Breath-test, Gastric scintigraphy), if available Endo-Flip
EQ-5L-5D

Sponsors

Universitätsklinikum Augsburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: patients with gastroparesis, which is diagnosed with an objective gastric emptying study (C13-breath test, gastric emptying scintigraphy) and GCSI-Score over 0 patient will or have received a G-POEM procedure

Exclusion criteria

Exclusion criteria: Patient denies follow-up Patient with gastroparesis without symptoms (GCSI Score = 0) Gastric emptying delay due to other circumstances excluding gastroparesis disease Patient unable to consent

Design outcomes

Primary

MeasureTime frame
Clinical success- reduction of GSCI-Score about 1 point of total score or reduction of at least 25% of two subscales after 3-6, 12 and 24 month.

Secondary

MeasureTime frame
absolute and relativ reduction of gastric emptying delay measured with an objective gastric emptying study adverse events frequency technical succress Change of life quality (EQ-5L-SD)

Countries

Austria, Germany, Switzerland

Contacts

Public ContactAlanna Ebigbo

Universitätsklinikum Augsburg

alanna.ebigbo@uk-augsburg.de+49821400161893

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026